Toujeo (insulin glargine 300 Units/mL) in addition to GLP1-RA

Prescribing Information can be found through the links in the Product Cards at the bottom of the page

Addition of Toujeo^® to GLP-1 RA was associated with significantly improved glycaemic control.⁹

DELIVER-G real-world retrospective analysis.

A real-world retrospective analysis in insulin-naïve adults with T2D inadequately controlled on GLP‑1 RA with or without oral antidiabetic drugs (N=271).⁹

DELIVER-G was a retrospective analysis of 271 people with Type 2 diabetes receiving GLP‑1 RA therapy who were insulin‑naive prior to subsequent treatment intensification with Toujeo^® (insulin glargine 300 U/mL). DELIVER‑G analysed data from a large US electronic medical record data source (IBM^® Explorys).⁹

Diabetes Products